Cargando…
Towards a Cure for HARS Disease
Histidyl-tRNA synthetase (HARS) ligates histidine to its cognate transfer RNA (tRNA(His)). Mutations in HARS cause the human genetic disorders Usher syndrome type 3B (USH3B) and Charcot-Marie-Tooth syndrome type 2W (CMT2W). Treatment for these diseases remains symptomatic, and no disease specific tr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956352/ https://www.ncbi.nlm.nih.gov/pubmed/36833180 http://dx.doi.org/10.3390/genes14020254 |
_version_ | 1784894571400921088 |
---|---|
author | Wilhelm, Sarah D. P. Kenana, Rosan Qiu, Yi O’Donoghue, Patrick Heinemann, Ilka U. |
author_facet | Wilhelm, Sarah D. P. Kenana, Rosan Qiu, Yi O’Donoghue, Patrick Heinemann, Ilka U. |
author_sort | Wilhelm, Sarah D. P. |
collection | PubMed |
description | Histidyl-tRNA synthetase (HARS) ligates histidine to its cognate transfer RNA (tRNA(His)). Mutations in HARS cause the human genetic disorders Usher syndrome type 3B (USH3B) and Charcot-Marie-Tooth syndrome type 2W (CMT2W). Treatment for these diseases remains symptomatic, and no disease specific treatments are currently available. Mutations in HARS can lead to destabilization of the enzyme, reduced aminoacylation, and decreased histidine incorporation into the proteome. Other mutations lead to a toxic gain-of-function and mistranslation of non-cognate amino acids in response to histidine codons, which can be rescued by histidine supplementation in vitro. We discuss recent advances in characterizing HARS mutations and potential applications of amino acid and tRNA therapy for future gene and allele specific therapy. |
format | Online Article Text |
id | pubmed-9956352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99563522023-02-25 Towards a Cure for HARS Disease Wilhelm, Sarah D. P. Kenana, Rosan Qiu, Yi O’Donoghue, Patrick Heinemann, Ilka U. Genes (Basel) Review Histidyl-tRNA synthetase (HARS) ligates histidine to its cognate transfer RNA (tRNA(His)). Mutations in HARS cause the human genetic disorders Usher syndrome type 3B (USH3B) and Charcot-Marie-Tooth syndrome type 2W (CMT2W). Treatment for these diseases remains symptomatic, and no disease specific treatments are currently available. Mutations in HARS can lead to destabilization of the enzyme, reduced aminoacylation, and decreased histidine incorporation into the proteome. Other mutations lead to a toxic gain-of-function and mistranslation of non-cognate amino acids in response to histidine codons, which can be rescued by histidine supplementation in vitro. We discuss recent advances in characterizing HARS mutations and potential applications of amino acid and tRNA therapy for future gene and allele specific therapy. MDPI 2023-01-18 /pmc/articles/PMC9956352/ /pubmed/36833180 http://dx.doi.org/10.3390/genes14020254 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Wilhelm, Sarah D. P. Kenana, Rosan Qiu, Yi O’Donoghue, Patrick Heinemann, Ilka U. Towards a Cure for HARS Disease |
title | Towards a Cure for HARS Disease |
title_full | Towards a Cure for HARS Disease |
title_fullStr | Towards a Cure for HARS Disease |
title_full_unstemmed | Towards a Cure for HARS Disease |
title_short | Towards a Cure for HARS Disease |
title_sort | towards a cure for hars disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956352/ https://www.ncbi.nlm.nih.gov/pubmed/36833180 http://dx.doi.org/10.3390/genes14020254 |
work_keys_str_mv | AT wilhelmsarahdp towardsacureforharsdisease AT kenanarosan towardsacureforharsdisease AT qiuyi towardsacureforharsdisease AT odonoghuepatrick towardsacureforharsdisease AT heinemannilkau towardsacureforharsdisease |